Go Pro

MaxCyte (MXCT) Competitors

MaxCyte logo
GBX 1.28 0.00 (0.00%)
As of 07/9/2026

MXCT vs. ADV, MAST, ABM, RGP, and LEAF

Should you buy MaxCyte stock or one of its competitors? MarketBeat compares MaxCyte with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MaxCyte include Advance Energy (ADV), MAST Energy Developments (MAST), African Battery Metals (ABM), Ross Group (RGP), and Leaf Clean Energy (LEAF). These companies are all part of the "business services" industry.

How does MaxCyte compare to Advance Energy?

Advance Energy (LON:ADV) and MaxCyte (LON:MXCT) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability and risk.

In the previous week, Advance Energy had 2 more articles in the media than MaxCyte. MarketBeat recorded 2 mentions for Advance Energy and 0 mentions for MaxCyte. Advance Energy's average media sentiment score of 1.27 beat MaxCyte's score of 0.00 indicating that Advance Energy is being referred to more favorably in the media.

Company Overall Sentiment
Advance Energy Positive
MaxCyte Neutral

24.0% of MaxCyte shares are owned by institutional investors. 1.9% of MaxCyte shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Advance Energy has higher earnings, but lower revenue than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Advance Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advance Energy£16K0.00N/A-£0.60N/A
MaxCyte£32.29M0.04-£45.08M-£40.00N/A

Advance Energy has a net margin of 0.00% compared to MaxCyte's net margin of -119.69%. Advance Energy's return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
Advance EnergyN/A N/A N/A
MaxCyte -119.69%-11.59%-11.07%

Summary

Advance Energy beats MaxCyte on 6 of the 10 factors compared between the two stocks.

How does MaxCyte compare to MAST Energy Developments?

MaxCyte (LON:MXCT) and MAST Energy Developments (LON:MAST) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk and dividends.

24.0% of MaxCyte shares are held by institutional investors. Comparatively, 0.2% of MAST Energy Developments shares are held by institutional investors. 1.9% of MaxCyte shares are held by insiders. Comparatively, 3.5% of MAST Energy Developments shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

MAST Energy Developments has a net margin of 0.00% compared to MaxCyte's net margin of -119.69%. MaxCyte's return on equity of -11.59% beat MAST Energy Developments' return on equity.

Company Net Margins Return on Equity Return on Assets
MaxCyte-119.69% -11.59% -11.07%
MAST Energy Developments N/A -695.03%-14.56%

In the previous week, MaxCyte's average media sentiment score of 0.00 equaled MAST Energy Developments'average media sentiment score.

Company Overall Sentiment
MaxCyte Neutral
MAST Energy Developments Neutral

MaxCyte has a beta of 1.13, indicating that its share price is 13% more volatile than the broader market. Comparatively, MAST Energy Developments has a beta of -0.58, indicating that its share price is 158% less volatile than the broader market.

MAST Energy Developments has lower revenue, but higher earnings than MaxCyte. MAST Energy Developments is trading at a lower price-to-earnings ratio than MaxCyte, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MaxCyte£32.29M0.04-£45.08M-£40.00N/A
MAST Energy Developments£1.26M1.63-£3.26M-£13.60N/A

Summary

MaxCyte beats MAST Energy Developments on 6 of the 11 factors compared between the two stocks.

How does MaxCyte compare to African Battery Metals?

African Battery Metals (LON:ABM) and MaxCyte (LON:MXCT) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

24.0% of MaxCyte shares are held by institutional investors. 1.9% of MaxCyte shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

African Battery Metals has a net margin of 0.00% compared to MaxCyte's net margin of -119.69%. African Battery Metals' return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
African Battery MetalsN/A N/A N/A
MaxCyte -119.69%-11.59%-11.07%

In the previous week, African Battery Metals' average media sentiment score of 0.00 equaled MaxCyte'saverage media sentiment score.

Company Overall Sentiment
African Battery Metals Neutral
MaxCyte Neutral

African Battery Metals has higher earnings, but lower revenue than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than African Battery Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
African Battery MetalsN/AN/AN/A-£4.50N/A
MaxCyte£32.29M0.04-£45.08M-£40.00N/A

Summary

African Battery Metals and MaxCyte tied by winning 4 of the 8 factors compared between the two stocks.

How does MaxCyte compare to Ross Group?

MaxCyte (LON:MXCT) and Ross Group (LON:RGP) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings and risk.

24.0% of MaxCyte shares are held by institutional investors. 1.9% of MaxCyte shares are held by insiders. Comparatively, 21.0% of Ross Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Ross Group has lower revenue, but higher earnings than MaxCyte.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MaxCyte£32.29M0.04-£45.08M-£40.00N/A
Ross Group£43K0.00-£3.18MN/AN/A

MaxCyte has a beta of 1.13, indicating that its share price is 13% more volatile than the broader market. Comparatively, Ross Group has a beta of 0.03, indicating that its share price is 97% less volatile than the broader market.

Ross Group has a net margin of 0.00% compared to MaxCyte's net margin of -119.69%. Ross Group's return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
MaxCyte-119.69% -11.59% -11.07%
Ross Group N/A N/A -131.93%

In the previous week, MaxCyte's average media sentiment score of 0.00 equaled Ross Group'saverage media sentiment score.

Company Overall Sentiment
MaxCyte Neutral
Ross Group Neutral

Summary

MaxCyte beats Ross Group on 5 of the 9 factors compared between the two stocks.

How does MaxCyte compare to Leaf Clean Energy?

Leaf Clean Energy (LON:LEAF) and MaxCyte (LON:MXCT) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

Leaf Clean Energy has a net margin of 0.00% compared to MaxCyte's net margin of -119.69%. Leaf Clean Energy's return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
Leaf Clean EnergyN/A N/A N/A
MaxCyte -119.69%-11.59%-11.07%

24.0% of MaxCyte shares are held by institutional investors. 1.9% of MaxCyte shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Leaf Clean Energy's average media sentiment score of 0.00 equaled MaxCyte'saverage media sentiment score.

Company Overall Sentiment
Leaf Clean Energy Neutral
MaxCyte Neutral

Leaf Clean Energy has higher earnings, but lower revenue than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Leaf Clean Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Leaf Clean Energy-£2M0.00N/A£142.80N/A
MaxCyte£32.29M0.04-£45.08M-£40.00N/A

Summary

Leaf Clean Energy beats MaxCyte on 5 of the 8 factors compared between the two stocks.

Get MaxCyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MXCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MXCT vs. The Competition

MetricMaxCyteMedical Devices IndustryMedical SectorLON Exchange
Market Cap£1.36M£2.15B£7.06B£2.84B
Dividend YieldN/A2.65%2.68%6.17%
P/E Ratio-0.0314.7027.15368.18
Price / Sales0.04129.45526.8884,612.72
Price / Cash1.9715.9929.2227.87
Price / Book0.014.6210.757.49
Net Income-£45.08M£144.75M£3.58B£5.89B
7 Day Performance5.35%0.28%-2.10%-0.48%
1 Month Performance16.36%1.64%3.32%-1.00%
1 Year Performance-43.86%0.29%28.17%61.74%

MaxCyte Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MXCT
MaxCyte
N/AGBX 1.28
flat
N/A-43.9%£1.36M£32.29MN/A80
ADV
Advance Energy
N/AN/AN/AN/A£2.67M£16KN/A75,000
MAST
MAST Energy Developments
N/AGBX 1.20
flat
N/A-24.1%£2.06M£1.26MN/A29,900
ABM
African Battery Metals
N/AN/AN/AN/A£2.00MN/AN/A127,000
RGP
Ross Group
N/AN/AN/AN/A£1.63M£43KN/A4,260

Related Companies and Tools


This page (LON:MXCT) was last updated on 7/13/2026 by MarketBeat.com Staff.
From Our Partners